Amicogen Inc operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Amicogen Inc with three other
companies in this sector in South Korea:
Caregen Co Ltd
(2017
sales of 57.89 billion Korean Won [US$51.29 million]
of which 100%
was Manufacture & Sale of Chemicals),
High Tech Pharm Company., Limited
(66.05 billion Korean Won [US$58.52 million]
), and
Yuyu Pharma Incorporated
(83.78 billion Korean Won [US$74.23 million]
).

Sales Analysis.
Amicogen Inc reported sales of 73.67 billion Korean Won (US$65.27 million)
for the
year ending
December of 2017.
This
represents
an
increase of 6.8%
versus 2016, when the company's sales were 68.97 billion Korean Won.
Sales at Amicogen Inc have increased during each of the previous five years
(and since 2012, sales have increased a total of 352%).